| SIMILAC ® PRO-SERIES | ENFAMIL INFANT FORMULAS |
Has HMOs, the most abundant solid | ✔ | × |
First leading formula with 2'-FL HMO | ✔ | × |
Backed by more than 20 years | ✔ | × |
| SIMILAC ® PRO-SERIES | ENFAMIL INFANT FORMULAS |
Has HMOs, the most abundant solid | ✔ | × |
First leading formula with 2'-FL HMO | ✔ | × |
Backed by more than 20 years | ✔ | × |
Reported significantly fewer respiratory infections1,2,*.
Shown to support immune cell response to RSV more like the breastfed infant3,†
* Similac with 2'-FL HMO compared to control formula without 2'-FL HMO, based on a post hoc analysis of adverse events.
† Study with Similac Pro-Advance®; using cells from infant’s blood that were challenged with RSV ex vivo.
‡ Based on pediatrician recommendations.
Enfamil is not a registered trademark of Abbott.
References: 1. Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649-658. 2. Reverri EJ, et al. Nutrients. 2018;10(10):1346. 3. Goehring KC, et al. J Nutr. 2016;146(12):2559-2566.
Your sample eligibility has been revoked. You are no longer eligible to send samples to patients.
Would you like to submit this sample eligibility approval request to ?
Click “Yes” to confirm.
You are about to decline 's sample eligibility request.
Would you like to approve ’s sample eligibility request? This will be the only eligible user that you can approve to send samples while they are linked to your account.
Click “Yes” to confirm.
Would you like to revoke ’s sample eligibility?
Click “Yes” to confirm.
Would you like to submit this request to revoke your sample eligibility?
Click “Yes” to confirm.
Request has been declined.
Please be aware that the website you have requested to view is intended for Healthcare Professionals and may not be owned or maintained by Abbott. A new window will open in your browser once you select “yes”. You can return to this site by clicking the back arrow.
Do you wish to continue and exit this website?